Position:Axxelis Expert Group
Arthur has over 22 years’ experience in research and drug development across a number of Pharmaceutical and Biotechnology companies across the world, including 10 years at Merck Serono as Senior Director for Neurodegenerative Diseases Research based in Switzerland.
Currently, Arthur is involved across several companies and initiatives. He is the President of the Geneva Pharma Network, the Founder and Head of the Scientific Advisory Board at Chord Therapeutics, Director of R&D for Parkinson’s UK and Director at Keepstone Therapeutics.
Utilising his broad experience in drug discovery and development in the neurology area, Arthur continues to drive the creation of new medicines for persons with Parkinson's, neuromyelitis optica and other neurological diseases.
Key Specialities and Interests
- Pre-clinical and clinical research in Neurodegenerative diseases
- Biopharmaceutical product strategies
- California Institute of Technology (Caltech), Pasadena, California
- Queen’s University, Kingston, Canada